ABDIIBRAHIM

Serial Number 90064573
Registration 6662343
700

Registration Progress

Application Filed
Jul 21, 2020
Under Examination
Approved for Publication
Dec 21, 2021
Published for Opposition
Dec 21, 2021
Registered
Mar 8, 2022

Trademark Image

ABDIIBRAHIM

Basic Information

Serial Number
90064573
Registration Number
6662343
Filing Date
July 21, 2020
Registration Date
March 8, 2022
Published for Opposition
December 21, 2021
Drawing Code
3

Status Summary

Current Status
Active
Status Code
700
Status Date
Mar 8, 2022
Registration
Registered
Classes
005

Rights Holder

Abdi Ibrahim Ilaç Sanayi ve Tic A.S.

09
Address
Resitpasa Mah.
Eski Büyükdere Cad. No: 4 Maslak
Sariyer Istanbul 34467
TR

Ownership History

Abdi Ibrahim Ilaç Sanayi ve Tic A.S.

Original Applicant
09
Sariyer Istanbul TR

Abdi Ibrahim Ilaç Sanayi ve Tic A.S.

Owner at Publication
09
Sariyer Istanbul TR

Abdi Ibrahim Ilaç Sanayi ve Tic A.S.

Original Registrant
09
Sariyer Istanbul TR

Legal Representation

Attorney
Jefferson F. Scher

USPTO Deadlines

Next Deadline
946 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2022-03-08)
Due Date
March 08, 2028
Grace Period Ends
September 08, 2028
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

23 events
Date Code Type Description Documents
Mar 8, 2022 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Dec 21, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Dec 21, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 1, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Nov 16, 2021 FIXD O ELECTRONIC RECORD REVIEW COMPLETE Loading...
Nov 12, 2021 ERRR O ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED Loading...
Nov 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Nov 9, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Nov 9, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Nov 9, 2021 ERFR I TEAS REQUEST FOR RECONSIDERATION RECEIVED Loading...
May 10, 2021 GNFR O FINAL REFUSAL E-MAILED Loading...
May 10, 2021 GNFN O NOTIFICATION OF FINAL REFUSAL EMAILED Loading...
May 10, 2021 CNFR R FINAL REFUSAL WRITTEN Loading...
May 5, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
May 4, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
May 4, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Nov 4, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Nov 4, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
Nov 4, 2020 GNRT F NON-FINAL ACTION E-MAILED Loading...
Nov 4, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Aug 19, 2020 MDSC E NOTICE OF DESIGN SEARCH CODE E-MAILED Loading...
Aug 18, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 24, 2020 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations used for the treatment of bone, joint, vertebral column, intestine, colon, skin, lung, eye, breast, ovary, cervix, stomach, bladder, kidney, head, brain, neck, and blood diseases and disorders; pharmaceutical preparations for the treatment of autoimmune, immune system, inflammatory, inflammatory bowel, gastrointestinal, genitourinary, musculoskeletal, muscular, dermatological, pulmonary, respiratory, oncological, hepatological, viral, metabolic, endocrine, cardiovascular, cardiopulmonary, sexual dysfunction, ophthalmic, neurological, hormonal, and psychiatric diseases and disorders; pharmaceutical preparations for use in oncology; pharmaceutical preparations for the treatment or prevention of dermatological, cardiovascular, hematological, bone, respiratory, central nervous system, endocrinological, circulatory, gastroenterological, stomach, digestive, hormonal, diabetic, muscular, rheumatic, immune system, ocular and metabolic diseases and disorders; pharmaceutical preparations to treat or prevent diabetes, coughs, colds, influenza, headaches and allergic reactions; anti-infectives; anti-inflammatories; vaccines; dietetic substances for medical purposes, namely, nutritional, vitamin and mineral supplements and preparations; antiallergic medicines, antidiarrheal medicines, medicines for intestinal disorders, motion sickness medicines, medicines for the treatment of gastrointestinal diseases; medicines for the treatment of cardiovascular and cerebrovascular diseases; prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders; medicinal herbal preparations; medicinal preparations for the treatment of diseases of the mouth in the form of sprays; medicinal creams for skin care; propolis for medicinal or therapeutic purposes; medicinal preparations for the treatment of infectious diseases and for use in oncology; medicinal preparations for the treatment of diseases of the mouth to be applied in the form of drops, capsules, tablets and compressed tablets; medicinal syrups for the treatment of cold, nasal and ocular allergic rhinitis, chronic idiopathic urticaria, acute and dry cough, chronic fever, achronic hemodialyses, hyperthyroid, liver and gall bladder disorders, sudden weight loss, non-adequate and non-balanced nutrition, mouth and throat disorders, malaise and fatigue, hyozincemia, respiratory infections, treatment of zinc and iron insufficiency, treatment of irritation of throat and bronchus, and treatment of bipolar manic episode; vitamin and mineral supplements; medicinal syrups containing sodium saccarine, glycerine, banana aroma, strawberry aroma, fruit aroma, orange flavour, sucralose, nicotimanid, fish oil, pelargonium sidoides, xanthan gum, bubble gum aroma, red food dye, peach aroma, yellow food dye, raspberry extract, indigo blue food dye, and caramel for the treatment of cold, nasal and ocular allergic rhinitis, chronic idiopathic urticaria, acute and dry cough, chronic fever, achronic hemodialyses, hyperthyroid, liver and gall bladder disorders, sudden weight loss, non-adequate and non-balanced nutrition, mouth and throat disorders, malaise and fatigue, hyozincemia, respiratory infections, treatment of zinc and iron insufficiency, treatment of irritation of throat and bronchus, and treatment of bipolar manic episode; anti-diabetic pharmaceuticals; pharmaceutical preparations for treating diabetes; pharmaceutical preparations for the prevention and treatment of ocular disorders or diseases, bacteria-based diseases or disorders, autoimmune diseases or disorders, kidney diseases or disorders, and diabetes; anti-infective preparations, antiviral preparations, antibiotics, antifungal preparations and vaccines; pharmaceutical skin lotions; pharmaceutical preparations for skin care; pharmaceutical preparations for the treatment of erectile dysfunction; pharmaceutical preparations for ophthalmological use; pharmaceutical preparations for treating hypertension; pharmaceutical antitussive-cold preparations; pharmaceutical preparations for skin wounds; pharmaceutical preparations for treating hypoglycemia; pharmaceutical preparations for the prevention of osteoporosis; pharmaceutical preparations for treating asthma; pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of bone diseases; pharmaceutical preparations for the treatment of infectious diseases; pharmaceutical preparations for treating respiratory diseases; pharmaceutical preparations for treating allergic rhinitis; pharmaceutical preparations for the treatment of musculo-skeletal disorders; pharmaceutical preparations for the treatment of eye diseases and conditions; pharmaceutical preparations for inhalation for the treatment of pulmonary hypertension; pharmaceutical preparations for treating diseases and disorders of the central nervous system; pharmaceutical preparations for treating allergic rhinitis and asthma; inhaled pharmaceutical preparations for the treatment of respiratory diseases and disorders; pharmaceutical preparations for the treatment of immune system related diseases and disorders; all of the foregoing being medicines for human health

Additional Information

Design Mark
The mark consists of three concentric circles divided in half where the center circle is blue on the left side and white on the right side, the next circle is white on the left side and blue on the right side and the outer circle is blue on the left side and white on the right side and is outlined in blue on the outer right side. The circle design appears to the left of the wording "ABDIIBRAHIM" in gray stylized font. The remaining white represents background and does not form part of the mark.
Color Claim
The color(s) blue, gray and white is/are claimed as a feature of the mark.

Classification

International Classes
005